FRANCISCO PARTNERS IV, L.P. sold $4.2M of GDRX (indirect holdings)
FRANCISCO PARTNERS IV, L.P. sold 1,193,951 indirectly-held shares of GoodRx Holdings, Inc. (GDRX) at an average of $3.52 ($3.50–$3.53, $4.20M total) across 6 trades over 2026-08-19 to 2026-08-21. Filed jointly with FRANCISCO PARTNERS IV-A, L.P. (10% owner), Francisco Partners GP IV, L.P. (10% owner), Francisco Partners GP IV Management Ltd (10% owner) and Francisco Partners Management, LP (10% owner).
How this was made
The 30-second read
Why it matters
The disclosed sale provides fresh data on insider sentiment, which can influence short‑term trading decisions.
Market read
Insider sell of $4.2M may trigger modest price movement; relevant for traders monitoring GoodRx and health‑tech sector.
What to watch
Potential tax‑loss harvesting or liquidity needs of the private equity fund.
Background
Form 4 filing reveals insider transactions; GoodRx is a publicly traded telehealth platform.
Ticker impact
Francisco Partners IV, L.P., a 10% owner, sold ~1.19M shares of GoodRx for $4.2M via open‑market transactions.
Possible modest downside pressure over the next few days.
A sizable insider sell by a major shareholder often leads to short‑term sell‑off, but the sale size is modest relative to market cap.
Market effects
May raise concerns for the digital health sector if other insiders follow suit.
Limited to U.S. equity markets where GoodRx trades.
Low global impact; primarily relevant to investors in GDRX.
Counterpoint
The sale could be a routine portfolio adjustment unrelated to company fundamentals.
Key entities
- companyGoodRx Holdings, Inc.
Digital health platform listed on NASDAQ.
- investorFrancisco Partners IV, L.P.
Private equity firm holding a 10% stake in GoodRx.
